Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Inflammation × Spironolactone × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4 Hyperandrogenism 3 Inflammation 1

Interventions

montelukast 1 Tablets 1 Spironolactone 1 Pioglitazone 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02689843 2019-11-12

AntiPCO

Shiraz University of Medical Sciences

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡